Founded at the Abramson Cancer Center at the University of Pennsylvania

Larry Shulman, MD

Deputy Director, Clinical Services, ACC & Co-Chair, PC3I Advisory Group

Director, Center for Global Cancer Medicine, Abramson Cancer Center
Professor, Department of Medicine, Perelman School of Medicine

Lawrence N. Shulman, MD, is the Deputy Director for Clinical Services of the Abramson Cancer Center at the University of Pennsylvania, and Director of the Center for Global Cancer Medicine. In this capacity, he leads the Cancer Quality program and strategic development of Cancer Services. He received his MD from Harvard Medical School and trained in Hematology and Oncology at the Beth Israel Hospital in Boston, MA.


Dr. Shulman is currently Chair of the Commission on Cancer and serves on the National Cancer Policy Forum of the National Academy. He is the former Chair of the American Society of Clinical Oncology Quality of Care Committee and the Commission on Cancer’s Quality Integration Committee.


A specialist in the treatment of patients with breast cancer, his research includes development of new cancer therapies, and implementation of cancer treatment programs in low-resource settings.


In this regard, Dr. Shulman serves as Senior Oncology Advisor to the non-profit organization Partners In Health (PIH). The PIH mission includes the establishment of national cancer treatment programs with the Ministries of Health in Rwanda and Haiti, programs for which he plays a seminal leadership role. He sits on the Vice Chancellor’s Advisory Council for Rwanda’s University for Global Health Equity. In addition, he helps to lead the development of the national oncology program in Botswana through the Botswana-UPenn Partnership. Dr. Shulman is a former member of ASCO’s International Affairs Committee and their Task Force on Global Oncology as an Academic Career. He led the World Health Organization’s review and revision of their Essential Medicines for Cancer from 2014-2017.

Related Publications